We are live on
!
Find out more
ACA
Atlas Capital Advisors Portfolio holdings
AUM
$875M
This Fund
S&P 500
This Quarter
Est. Return
-13.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$590M
AUM Growth
-$53.8M
(-8.4%)
Cap. Flow
+$45.6M
Cap. Flow
% of AUM
7.73%
Top 10 Holdings %
Top 10 Hldgs %
26.41%
Holding
1,042
New
133
Increased
224
Reduced
244
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$28.5M |
| 2 |
iShares Core Conservative Allocation ETF
AOK
|
+$18.5M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$3.73M |
| 4 |
Schwab International Small-Cap Equity ETF
SCHC
|
+$3.18M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$10.3M |
| 2 |
Global X MLP ETF
MLPA
|
+$6.07M |
| 3 |
Vanguard Health Care ETF
VHT
|
+$5.11M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$3.89M |
| 5 |
Fidelity MSCI Information Technology Index ETF
FTEC
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.93% |
| 2 | Consumer Staples | 8.92% |
| 3 | Healthcare | 5.53% |
| 4 | Financials | 4.77% |
| 5 | Consumer Discretionary | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
GSK
GSK
$106B
| $658K | 0.11% |
12,101
-63
| -0.5% | -$3.48K |
|
|
MITSY
152
DELISTED
MITSUI & CO LTD ADR (US)
MITSY
| $657K | 0.11% |
+1,495
| New | +$657K |
|
153
Fidelity MSCI Financials Index ETF
FNCL
$2.4B
| $651K | 0.11% |
14,591
-33,791
| -70% | -$1.65M |
|
154
Northrop Grumman
NOC
$81.2B
| $648K | 0.11% |
1,354
+40
| +3% | +$18.4K |
|
155
Corning
GLW
$143B
| $642K | 0.11% |
20,365
-3,911
| -16% | -$135K |
|
156
Nerdy
NRDY
$96.1M
| $639K | 0.11% |
+300,000
| New | +$977K |
|
|
HIT
157
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
| $634K | 0.11% |
6,710
-154
| -2% | -$14.6K |
|
158
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $629K | 0.11% |
14,744
-368
| -2% | -$16.7K |
|
159
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
| $624K | 0.11% |
24,579
+4,089
| +20% | +$107K |
|
160
FedEx
FDX
$75.4B
| $623K | 0.11% |
2,748
+2,642
| +2,492% | +$564K |
|
161
Diamondback Energy
FANG
$52.7B
| $620K | 0.11% |
5,121
+385
| +8% | +$52.8K |
|
162
Equinor
EQNR
$92.4B
| $615K | 0.1% |
17,697
+1,641
| +10% | +$58.6K |
|
163
Unum
UNM
$14.3B
| $609K | 0.1% |
17,912
+9,850
| +122% | +$333K |
|
164
Novartis
NVS
$297B
| $609K | 0.1% |
7,206
-4,582
| -39% | -$402K |
|
165
Halliburton
HAL
$26.6B
| $603K | 0.1% |
19,216
+3,151
| +20% | +$117K |
|
166
iShares S&P Small-Cap 600 Value ETF
IJS
$8.34B
| $601K | 0.1% |
6,756
| – | – |
|
167
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.89B
| $599K | 0.1% |
+12,558
| New | +$648K |
|
168
Tesla
TSLA
$1.3T
| $596K | 0.1% |
+2,655
| New | +$725K |
|
|
LPRO
169
DELISTED
Open Lending Corp
LPRO
| $593K | 0.1% |
58,000
| – | – |
|
170
Parker-Hannifin
PH
$135B
| $588K | 0.1% |
2,388
| – | – |
|
171
Oracle
ORCL
$423B
| $586K | 0.1% |
8,384
-3,559
| -30% | -$261K |
|
172
RTX Corp
RTX
$301B
| $585K | 0.1% |
6,085
| – | – |
|
173
Merck
MRK
$318B
| $577K | 0.1% |
6,327
-1,388
| -18% | -$123K |
|
174
CBRE Group
CBRE
$42.9B
| $577K | 0.1% |
7,832
+98
| +1% | +$7.89K |
|
175
Diageo
DEO
$53.6B
| $574K | 0.1% |
3,295
-117
| -3% | -$22.3K |
|
Similar funds
MC
AGDI
SA
F1I
HT
OHA
WCM
GKFF
Atlas Capital Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Atlas Capital Advisors held 1,042 positions worth $590M, down 8.4% from $644M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Atlas Capital Advisors deployed $45.6M of net new capital in Q2 2022, opening 133 new positions and adding to 224 existing holdings. Its largest new stake was iShares Core Conservative Allocation ETF: 518,500 shares worth $17.9M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $10.3M trimmed.
- Atlas Capital Advisors's largest Q2 2022 buy was iShares Core Conservative Allocation ETF: 518,500 shares worth $17.9M.
- Atlas Capital Advisors added most to Procter & Gamble in Q2 2022, an estimated $28.5M increase.
- Atlas Capital Advisors's biggest Q2 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $10.3M.
- Atlas Capital Advisors fully exited iShares California Muni Bond ETF in Q2 2022, selling an estimated $2.12M.
- Atlas Capital Advisors's ten largest holdings make up 26% of its $590M portfolio in Q2 2022.
- Atlas Capital Advisors opened 133 new positions and closed 71 in Q2 2022.
- Atlas Capital Advisors's portfolio value fell 8.4% quarter-over-quarter to $590M.
Based on Atlas Capital Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.